Icon Advisers Inc Innoviva, Inc. Transaction History

Icon Advisers Inc

  • $426 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 03, 2018
SELL
$13.44 - $17.59 $423,749 - $554,595
-31,529 Closed
0 $0
Q4 2017

Feb 06, 2018
BUY
$11.73 - $14.75 $107,916 - $135,700
9,200 Added 41.2%
31,529 $447,000
Q3 2017

Nov 08, 2017
BUY
$12.06 - $14.12 $269,287 - $315,285
22,329
22,329 $315,000

Others Institutions Holding INVA

# of Institutions
240
Shares Held
77M
Call Options Held
53.9K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.26B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Icon Advisers Inc Portfolio

Follow Icon Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Icon Advisers Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email